Author/Authors :
Dang-Tan, Tam GlaxoSmithKline, Research Triangle Park, Durham, USA , Zhang, Shiyuan GlaxoSmithKline, Mississauga, Canada , Tavares, Ruben V. GlaxoSmithKline, Mississauga, Canada , Stutz, Melissa JSS Medical Research Inc, Saint Laurent, Canada , Corriveau, Diane GlaxoSmithKline, Mississauga, Canada , Stanford, Richard H. GlaxoSmithKline, Research Triangle Park, Durham, USA , Lin, Xiwu GlaxoSmithKline, Collegeville, PA, USA , Nadeau, Gilbert A. GlaxoSmithKline, Mississauga, Canada , Simidchiev, Alexander GlaxoSmithKline, Mississauga, Canada , Parsons, Daria JSS Medical Research Inc, Saint Laurent, Canada , Sampalis, John S. JSS Medical Research Inc, Saint Laurent, Canada
Abstract :
Background. Chronic obstructive pulmonary disease (COPD) prevalence in Canada has risen over time. COPD-related
exacerbations contribute to the increased health care utilization (HCU) in this population. This study investigated the impact of
exacerbations on COPD-related HCU. Methods.This retrospective observational cohort study used patient data from the Qu´ebec
provincial health insurance databases. Eligible patients with a newHCUclaim with a diagnostic billing for COPD during 2001–2010
were followed until March 31, 2011. Exacerbation rates and time to first exacerbation were assessed. Unadjusted analyses and
multivariablemodels compared the rate ofHCUby exacerbation classification (any [moderate/severe],moderate, or severe). Results.
The exacerbation event rate in patients with an exacerbation was 34.3 events/100 patient-years (22.7 for moderate exacerbations
and 11.6 for severe exacerbations). Median time to first exacerbation of any classification was 37 months. In unadjusted analyses,
COPD-related HCU significantly increased with exacerbation severity. In the multivariable, HCU rates were significantly higher
after exacerbation versus before exacerbation (𝑝 < 0.01) for patients with an exacerbation or moderate exacerbations. For severe
exacerbations, general practitioner, respiratory specialist, emergency room, and hospital visits were significantly higher after
exacerbation versus before exacerbation (𝑝 < 0.001). Conclusions. Exacerbations were associated with increased HCU, which was
more pronounced for patients with severe exacerbations. Interventions to reduce the risk of exacerbations in patients with COPD
may reduce disease burden.